NIDA Mentored-facilitated training award in Substance Use Disorders Dissemination solicitation


Supported by the National Institute on Drug Abuse (NIDA) from the National Institutes of Health (NIH) and sponsored by the Society for Adolescent Health and Medicine (SAHM)         

DATES AND DEADLINE INFORMATION
  • Deadline for receipt of application:  November 13, 2020
  • Notification of award: December 4, 2020
  • Funding period: January 2021 – December 2021     

Application packages are to be submitted electronically to [email protected]g  


 

INTRODUCTION
Accelerating the dissemination of SUD research findings and encouraging the implementation of evidence-based practices in health care settings is a priority for NIDA and represents the core mission of the NIDA CTN Dissemination Initiative.  This initiative uses collaboration between expert clinicians, clinical researchers, experienced trainers, and NIDA staff to rapidly disseminate research findings from NIDA’s vast scientific portfolio to a variety of stakeholders, including policy-makers, program administrators and frontline prevention and treatment providers.
 
SAHM has partnered with NIDA to fund training awards to support the development of expertise in substance use disorders (SUD) through completion of a mentored experience and project focused on dissemination of SUD treatment research. The NIDA Mentor-Facilitated Training Award goals are: 1) to promote and improve knowledge of evidence-based SUD treatment among health care providers, 2) to promote dissemination of substance use disorder research findings, 3) to promote the adoption of evidence-based approaches in medical settings, and 4) to facilitate the academic growth and development of future leaders in SUD management.
 
This award cannot be used to conduct basic or clinical research studies or trials. Awardees are to develop and execute a plan designed to increase their knowledge of SUD and SUD treatment and complete a project aimed at improving the dissemination and/or adoption of SUD research findings. Secondary data analysis may be completed in pursuit of these aims, provided the project proposed is eligible for IRB exemption and has a dissemination/adoption focus. Applications proposing non-exempt research involving human subjects that must be reviewed by an IRB under the requirements of the U.S. Department of Health and Human Services (HHS) regulations at 45 CFR part 46 will not be accepted.
 

PURPOSE OF THE AWARD
The purpose of the award is to enhance a trainee’s knowledge of SUD treatment research and the dissemination and adoption of evidence-based SUD treatment practices through a plan that will:

  • Provide the trainee with experience that eventually fosters interest in either a clinical career providing evidence-based management of SUD in medical settings or potentially stimulates interest in securing a NIH career development or other grant award to pursue implementation and related research in the field of substance misuse and substance use disorder in subsequent years.  
  • Provide the trainee with education and experience in effective dissemination of research findings and the implementation/adoption of research in clinical practice.  Applicants are encouraged to develop projects that address or improve upon current gaps in the dissemination of research findings or implementation/adoption of evidence-based treatment practices. Project updates will be shared at the NIDA CTN Annual meeting. Project results will be presented at the 2022 SAHM Annual Meeting. Poster presentations are acceptable. The trainee is strongly encouraged to develop a manuscript for submission for publication in a peer-reviewed journal.  
  • Link the trainee with an experienced mentor to guide and facilitate an up to one year-long mentored experience, culminating in a project related to dissemination and/or adoption of SUD research findings.  
  • Provide the trainee with a mentored opportunity to learn about key areas of SUD and SUD treatment strategies through systematic literature review, attendance at conferences and workshops, and interaction with leading experts in the field.


MENTORSHIP
The applicant should work in an active, progressive environment that intimately involves the applicant in different facets of SUD treatment. Award recipients should be matched with a faculty mentor with established SUD treatment expertise.  It is recommended that the mentor also have dissemination and implementation science expertise. The mentor is responsible for providing a letter of support with plans for regular phone or video meetings; assisting with planning and execution of the project; and assisting with developing the poster presentation.  This award will provide a mentor stipend. Applicants are encouraged to develop a project related to ongoing work done by their mentor. More than one mentor may be proposed.
 

APPLICANT ELIGIBILITY
The applicant may be a resident in an approved residency training program, a first-year graduate, or entering first year faculty member. Eligible candidates will not have a career development award.

 
PROJECT EXAMPLES AND RECOMMENDED TOPIC AREAS
For this Mentored training award, NIDA and SAHM encourage clinically relevant applications with a focus on treatment of substance use disorders and the dissemination of research findings or facilitation of adoption of evidence-based practices in clinical settings. This award cannot support new, free-standing pilot studies, clinical trials, or clinical research studies. Any proposed activities such as secondary analyses or quality improvement initiatives must be eligible for IRB exemption. Projects should focus on improving dissemination of treatment research and/or facilitating implementation of evidence-based practices.  Data collection is not permitted, but secondary data analysis may be permitted if the proposed project is a good fit with the mission of the Dissemination Initiative. Focus groups and informal interviews may be conducted if eligible for IRB exemption.
 
Examples of appropriate activities and projects include but are not limited to:
  • Analysis of de-identified data from completed clinical trials such as those found on the NIDA Data Share website (https://datashare.nida.nih.gov/) to inform dissemination or implementation efforts;
  • Analysis of de-identified data from electronic health records or registries such as the ACEP Clinical Emergency Data Registry (https://www.acep.org/cedr/) to characterize availability of data on substance use or practice patterns, identify gaps in the provision of evidence-based practices, and/or identify needs for  dissemination or implementation.
  • Reviewing available curricula or training programs, identifying status of education on SUD diagnosis and treatment in various settings, and proposing and conducting activities to improve training;
  • Identifying best practices or effective strategies or models for SUD education;
  • Developing materials that could be used for quality improvement or integration of an evidence-based approach or process in a medical setting and conducting activities for quality improvement or adoption;
  • Identifying training gaps and research findings and/or products developed by NIDA or other federal agencies or professional associations that could bridge gaps, identifying potential partners for effective dissemination of these findings and disseminating them within existing or newly developed communication channels;

Coursework to strengthen formal training in substance use disorder research and; 

  • Other activities consistent with the goals of the Dissemination Initiative to accelerate the dissemination of research findings and implementation or adoption of evidence-based SUD treatment in clinical practice.

AWARD ADMINISTRATION, APPLICATION, AND SELECTION PROCESS
SAHM will administer the NIDA Mentored Training Award.  SAHM conducts the planning, on-site coordination, and evaluation of applications. Candidates cannot have had previous or simultaneous funding from the National Institutes of Health (NIH) or research funding sources. Eligible candidates may not have a training award.
 
Award recipients are selected through a competitive process. Applicants must submit the following information:
 
  • A completed application form, abstract, candidate statement, training plan, project description, timeline for the award year, budget and budget justification, literature cited, and other support. The project description will include objectives, background information, and method or proposed activities.  
  • A letter detailing any current and previous funding.  
  • The applicant’s and mentor’s current biosketch.  
  • A letter of support from a proposed mentor.  
  • A letter of support from their current department chair (or appropriate program director).  
  • A letter of support from a proposed co-mentor (if applicable).

Each application will be reviewed by researchers, program managers and/or clinicians who are involved and informed in dissemination of findings from the field of SUD. Each application will be judged primarily by the likelihood of producing dedicated, qualified clinicians and champions in the field of medicine and SUD as indicated by 1) the qualifications of the applicant, 2) the qualifications of the mentor, 3) the overall merit of the training plan and project, 4) the adequacy of the proposed budget to meet the objectives, and 5) the willingness of the institution to provide the necessary facilities and support to complete the project as described.

 
PROGRAM ACTIVITIES AND REQUIREMENTS

Orientation: Attendance to the orientation will be mandatory for all trainees, where awardees will be presented all relevant information associated with the MFT program. Some of the topics that will be covered at the orientation will relate to expenses, focusing on cost of travel, lodging and any other expenses associated with attending conferences. Also, the requirements for the Annual CTN Steering Committee Meeting will be discussed such as the poster and oral presentations.
 
Progress and Final Reports: The trainee and designated mentor are required to submit a 6-month narrative progress report and a final narrative report at the end of the performance period. Failure to provide the report may negatively impact your institution’s ability to apply for future awards. These reports will be submitted to the sponsoring organization for subsequent submission to NIDA.  In the event that the awardee’s project is not completed at the end of the designated performance period, and appropriate approvals to continue have been granted, the final report must still be submitted as an outline of work done and projections for work/expenditures remaining.
 
Institutional Annual Meeting: Attendance is expected at the 2022 SAHM annual meeting, where the awardees will present a poster abstract of their work following the completion of the award.
 
NIDA CTN Meeting: Trainees are also expected to attend the NIDA Clinical Trials Network Annual Steering Committee Meeting, while mentors are heavily encouraged. The Coordination Office will ensure that funds from each stipend are used to coordinate air travel and hotel accommodations. Any remaining funds will be returned to the trainee to assist with research projects. At the meeting, each trainee will be required to participate in poster and oral presentations of their project to the conference attendees. Guidelines about both the poster and oral presentations will be provided during the awardee orientation.
 
Publications: All discoveries resulting from work supported in part by the NIDA Award should be made available to the public and scientific community through approved scientific channels such as national meetings and peer reviewed publications. Publications will acknowledge the support of NIDA and SAHM. Two reprints of each publication should be forwarded to SAHM and NIDA.

 
PROGRAM EVALUATION
Awardees will be contacted annually by the Dissemination Initiative following completion of the funding year regarding career paths, ongoing dissemination or implementation activities, leadership in promoting the adoption of evidence-based practices in clinical settings, subsequent grants/contracts obtained, and publications. Awardees will be expected to respond to this outreach.

<Back to top> 

PROGRAM PROMOTION
The NIDA Mentor-Facilitated Training Award will be promoted and advertised through institutional marketing vehicles such newsletters, website, member emails, exhibits, etc. Individuals directly involved with residents, including training directors and program directors, will be contacted through list serves to encourage their residents to apply.

 
BUDGET
The budget consists of up to $10,000 for the trainee stipend and up to $2,000 stipend for the mentor, for a total award of $12,000.  Awards are contingent on availability of funds.  Funds may be used for travel to the 2022 SAHM Annual Meeting and will be used for the CTN Annual Meeting. Funds may also be used for educational and resource materials/courses.

 
SUPPORT FACILITIES
The applicant must submit letters of support if the proposed project uses facilities not routinely available to or directly under the supervision of SAHM.
 

INSTITUTIONAL SUPPORT
The applicant assumes responsibility for conducting the project and the mentor for supervising the work and advanced education of the applicant and associates. The application must show that adequate and appropriately equipped space will be available during the funding period. If a project proposes secondary data analysis or when appropriate, projects must be eligible for and obtain IRB exemption.

 
SYNOPSIS
The NIDA Mentor-Facilitated Training Award in Substance Use Disorders is designed to provide opportunities to enhance knowledge of SUD and SUD treatment, to promote dissemination of substance use disorder research findings, and to promote the adoption of evidence-based approaches in clinical settings.  By participating in this program, awardees gain valuable training and mentored experience in the management of substance use and SUD, facilitate the dissemination of research findings in medical settings, and work on improving treatment of SUD. The goal is for more healthcare providers to choose to continue their education and training in the field, providing a stronger integrated health workforce, both in numbers and expertise.

 
TERMS OF THE AWARD
 
Duration: Applications will be accepted for one-year of training only.
 
Extension of Award Period: In unusual circumstances, arrangements can be made for an extension of an award. Such a request must be made by the trainee at least 60 days before the expiration date of the award. This request must be made in writing, specify reasons for requesting the extension, and state a new expiration date. Project extensions of greater than six months will not be considered.
 
Change of Status of Designated Mentor or Trainee: If the trainee changes affiliations or ceases work in the field for which the award was made, the award will terminate and the remaining balance will be returned unless the trainee and his or her new institution demonstrate the ability to successfully complete the planned project and the plan for this is approved. If the named mentor changes affiliations or ceases work in the field for which the award was made, the award will terminate and the remaining balance will be returned unless another appropriate mentor or plan to ensure appropriate mentoring is identified and approved.
 
Location of work: Awards are for projects in the United States at an accredited medical school, medical center, or institution affiliated with a university teaching program. The trainee, with the direction of the mentor, will make all arrangements for conduct of the proposed projects.
 
Liability of the Sponsoring Organization and National Institute on Drug Abuse: SAHM and NIDA assume no financial liability if patient care responsibilities of any kind are undertaken by the NIDA trainee or mentor. The mentor, the trainee, and their respective institution(s) acknowledge that NIDA and the sponsoring organization are not legally liable for the conduct of the trainee or the mentor and associate investigators.
 
Patent Policy: The mentor, the awardee, and their respective institution(s) acknowledge that if a patentable invention or discovery is conceived, or conceived and reduced to practice by the award during the term of the award year, NIDA and the sponsoring organization must be apprised of the invention and the institution’s plans for protecting such invention under existing institutional patent policy. The sponsoring organization will defer to institutional policies where they are in compliance with those of the Federal government. NIDA and the sponsoring organization reserves the right where the institution has no patent policy, or policies not in compliance with those of the federal government, to claim rights and interests in the invention or discovery consistent with FAR Clause 52.227-11, Patent Rights- Ownership by the Contractor.


<Back to top>

More in this Section